Clinical Trials Related to Sandostatin LAR Depot (Octreotide Long Acting)
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study. [Completed]
Pegvisomant And Sandostatin LAR Combination Study [Completed]
Preoperative Octreotide Treatment of Acromegaly [Active, not recruiting]
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea [Completed]
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed [Completed]
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma [Active, not recruiting]
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients [Active, not recruiting]
Ultrasound Guided Sandostatin LAR Injection in Acromegaly [Recruiting]
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Completed]
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly [Recruiting]
Sandostatin for Patients With Androgen Independent Prostate Cancer [Recruiting]
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer [Active, not recruiting]
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer [Active, not recruiting]
Acute Application of Pegvisomant and Octreotide in Acromegaly [Completed]
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly [Completed]
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction [Completed]
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Completed]
Prediction of Tumor Shrinkage in Acromegaly [Completed]
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Completed]
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients [Completed]
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma [Completed]
Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome [Terminated]
Multicenter Study of IMC-A12 in Combination With Depot Octreotide in Patients With Carcinoid or Islet Cell Cancer [Not yet recruiting]
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) [Recruiting]
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas [Completed]
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients [Completed]
Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers [Recruiting]
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor [Recruiting]
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome [Recruiting]
Octreotide in Treating Patients With Cancer-Related Malignant Ascites [Recruiting]
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache [Recruiting]
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer [Active, not recruiting]
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis [Active, not recruiting]
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut [Active, not recruiting]
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Completed]
Evaluation of the Efficacy of Long-Acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma [Completed]
A Study of Octreotide Depot Vs Saline Control in Pediatric Hypothalamic Obesity Patients [Completed]
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Completed]
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity [Completed]
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Active, not recruiting]
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [Withdrawn]
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients [Completed]
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer [Active, not recruiting]
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Completed]
Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly [Completed]
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma [Recruiting]
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. [Active, not recruiting]
Extension Study of the Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy [Completed]
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea [Completed]
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]
Extension Study of Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy [Completed]
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [No longer recruiting]
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Completed]
Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide [Recruiting]
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR [No longer recruiting]
Octreotide Efficacy and Safety in First-Line Acromegalic Patients [Suspended]
Octreotide in Severe Polycystic Liver Disease [Recruiting]
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma [Active, not recruiting]
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]
Evaluation of Octreotide LAR in Prevention of Chemotherapy-Induced Diarrhea [Recruiting]
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction [Completed]
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly [Recruiting]
Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease [Recruiting]
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors [Not yet recruiting]
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer [Recruiting]
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma [Recruiting]
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide [Recruiting]
Preoperative Octreotide Treatment of Patients With Acromegaly [No longer recruiting]
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Recruiting]
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma [Completed]
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly [Recruiting]
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide [Completed]
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia [Completed]
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Recruiting]
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors [No longer recruiting]
Treatment of Orthostatic Intolerance [Recruiting]
Alternatives to Large Volume Paracentesis Study [Recruiting]
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers [Recruiting]
Vasoconstrictors as Alternatives to Albumin After LVP (Large-Volume Paracentesis) in Cirrhosis [Recruiting]
Treatment of Orthostatic Hypotension in Autonomic Failure [Recruiting]
Open Label Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel 120 mg in Acromegalic Subjects Who Are Biochemically Controlled on Long Term Treatment With Octreotide LAR 10 or 20 mg [Not yet recruiting]
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly [No longer recruiting]
Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-Octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer [No longer recruiting]
Pediatric Hypothalamic Obesity [Completed]
Prader Willi Syndrome and Appetite [Recruiting]
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors [Not yet recruiting]
Treatment of the Dumping Syndrome With Lanreotide Autogel® [Recruiting]
The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors [Recruiting]
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer [No longer recruiting]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [No longer recruiting]
Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy [Recruiting]
Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Recruiting]
Fat Cell Size in Insulin Resistance [Recruiting]
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome [Recruiting]
Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Recruiting]
Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma [Recruiting]
Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP) [Terminated]
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome [Not yet recruiting]
131MIBG to Treat Malignant Pheochromocytoma [Recruiting]
Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors [Recruiting]
|
